search
Back to results

Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.

Primary Purpose

Urinary Incontinence, Stress

Status
Terminated
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
weighted vaginal cones
Biofeedback
Sponsored by
Queen's University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Incontinence, Stress focused on measuring urodynamic stress incontinence, weighted vaginal cones, pelvic floor biofeedback, randomized controlled trial

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Females, between the ages of 18-65 years, will be entered into this study. Additional inclusion criteria are a history of urinary stress incontinence and multichannel cystometry confirming the presence of genuine stress incontinence (GSI). Exclusion Criteria: urodynamic identification detrusor instability active (untreated or resistant) urinary tract infection any other disease that is felt by the investigators to potentially interfere with participation (e.g. arthritis limiting dexterity and thus interfering with the insertion and removal of vaginal cones) previous treatment with pelvic floor physiotherapy with biofeedback or functional electric stimulation for urinary incontinence previous use of weighted vaginal cones previous anti-incontinence surgery significant pelvic organ prolapse or those with abnormal vaginal anatomy (the Pelvic Organ Prolapse Quantification (POP-Q) system of scoring for prolapse will be used, Grade > III) use of concomitant treatments during the trial or the start of new medications that may alter continence mechanism inability to understand instructions in French or English or provide informed consent (e.g., psychiatric disease). pregnancy (which may alter pelvic anatomy may over the course of the study and thus make evaluation of treatment methods impossible)

Sites / Locations

  • Kingston General Hospital, Queen's University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

a

b

Arm Description

Weighted vaginal cones used to perform pelvic floor exercises

Biofeedback

Outcomes

Primary Outcome Measures

Urodynamic studies

Secondary Outcome Measures

Cough stress test
Standardized fixed bladder volume pad test
I-QOL questionnaire
Urogenital Distress Inventory

Full Information

First Posted
October 31, 2005
Last Updated
January 25, 2016
Sponsor
Queen's University
search

1. Study Identification

Unique Protocol Identification Number
NCT00247286
Brief Title
Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.
Official Title
A Randomised, Single-Blind Comparison of Pelvic Floor Muscle Exercises With Biofeedback Versus Weighted Vaginal Cones in the Management of Genuine Stress Incontinence : A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Terminated
Why Stopped
slow recruitment
Study Start Date
September 2001 (undefined)
Primary Completion Date
January 2007 (Actual)
Study Completion Date
October 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the objective (urodynamic) cure rates and effect on patient quality of life after six months of treatment for two different nonsurgical management options for genuine stress urinary incontinence in females: weighted vaginal cones and formal supervised pelvic floor physiotherapy with biofeedback. Hypothesis: Assuming a minimum of six months of treatment, weighted vaginal cones are as effective as a formal supervised program of pelvic floor physiotherapy with biofeedback for the treatment of uncomplicated genuine stress urinary incontinence in females.
Detailed Description
Background and Rationale Urinary incontinence is a widespread and debilitating medical problem, with an estimated prevalence of between 17-45% in adult women. Genuine stress incontinence is the most common form of urinary incontinence in women, with objective diagnosis made via urodynamics. Urinary continence is maintained when the urethral resistance (pressure) is greater than the intravesical pressure. Genuine stress incontinence occurs when pressure transmission to the urethra is compromised by poor anatomic support of the proximal urethra resulting from weakened pelvic floor musculature and/or defective endopelvic fascia. While the gold standard for treatment of genuine stress incontinence is still considered to be surgical, there is renewed interest among both patients and surgeons for nonsurgical (conservative) management. The goal of conservative therapy is to restrengthen and retrain the pelvic floor muscles to improve urethral pressure transmission and thus improve the continence mechanism. Nonsurgical therapies include PFME with or without biofeedback, and weighted vaginal cones. PFME with biofeedback are widely accepted as an effective conservative treatment for genuine stress incontinence, with subjective cure rates estimated to be as high as 70 percent. However, to date, objective cure rates as defined by urodynamics have not been well documented. Similarly, while limited studies suggest that vaginal cone therapy results in a subjective cure rate of 60%, objective cure rates still have not been determined. With growing clinic and surgical waiting lists and rising hospital costs, weighted vaginal cones, if objectively proven to be a comparably effective alternative to physiotherapy, will offer an effective management option for stress incontinence, thus, perhaps avoiding referral to a tertiary hospital for physiotherapy, and surgery. We hypothesize that following a minimum of six months of treatment, weighted vaginal cones would be as effective as a formal supervised program of pelvic floor physiotherapy with biofeedback for the treatment of uncomplicated genuine stress urinary incontinence in females. We are thus seeking to evaluate the feasibility of a randomized clinical trial. Method An estimated 60 women identified from ambulatory clinics with multichannel urodynamics documenting genuine stress urinary incontinence will be needed to participate in this single-blind, randomized pilot study. Once entered, patients will be randomized to receive one of two different nonsurgical treatments: PFME with biofeedback or weighted vaginal cones. The patients will chart compliance to treatment for the duration of the study. A quality of life questionnaire will be completed at the beginning and end of the trial, along with a subjective assessment of incontinence severity via a standardized questionnaire. The study period will be six months. Upon completion of the study, patients will undergo repeat multichannel urodynamics and perineal pad testing to determine if genuine stress incontinence is present or absent and thus whether objective cure has been achieved. Results will be analyzed and compared statistically.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Stress
Keywords
urodynamic stress incontinence, weighted vaginal cones, pelvic floor biofeedback, randomized controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
a
Arm Type
Experimental
Arm Description
Weighted vaginal cones used to perform pelvic floor exercises
Arm Title
b
Arm Type
Active Comparator
Arm Description
Biofeedback
Intervention Type
Behavioral
Intervention Name(s)
weighted vaginal cones
Intervention Type
Behavioral
Intervention Name(s)
Biofeedback
Intervention Description
Pelvic floor muscles exercises performed with a biofeedback machine
Primary Outcome Measure Information:
Title
Urodynamic studies
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Cough stress test
Time Frame
6 months
Title
Standardized fixed bladder volume pad test
Time Frame
6 months
Title
I-QOL questionnaire
Time Frame
6 months
Title
Urogenital Distress Inventory
Time Frame
6 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Females, between the ages of 18-65 years, will be entered into this study. Additional inclusion criteria are a history of urinary stress incontinence and multichannel cystometry confirming the presence of genuine stress incontinence (GSI). Exclusion Criteria: urodynamic identification detrusor instability active (untreated or resistant) urinary tract infection any other disease that is felt by the investigators to potentially interfere with participation (e.g. arthritis limiting dexterity and thus interfering with the insertion and removal of vaginal cones) previous treatment with pelvic floor physiotherapy with biofeedback or functional electric stimulation for urinary incontinence previous use of weighted vaginal cones previous anti-incontinence surgery significant pelvic organ prolapse or those with abnormal vaginal anatomy (the Pelvic Organ Prolapse Quantification (POP-Q) system of scoring for prolapse will be used, Grade > III) use of concomitant treatments during the trial or the start of new medications that may alter continence mechanism inability to understand instructions in French or English or provide informed consent (e.g., psychiatric disease). pregnancy (which may alter pelvic anatomy may over the course of the study and thus make evaluation of treatment methods impossible)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie-Andree Harvey, MD MSc
Organizational Affiliation
Queen's University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kingston General Hospital, Queen's University
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 4P8
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.

We'll reach out to this number within 24 hrs